United States · FDA National Drug Code directory
ELEPSIA XR 1000 MG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80705-100_3c463bee-1191-4cab-b4d0-367673db19ef
- Product NDC
- 80705-100
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- levetiracetam
- Labeler
- TRIPOINT THERAPEUTICS, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210212
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (80705-100-02) / 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 80705-100-02
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80705-100-30) · 80705-100-30
- 1 BLISTER PACK in 1 CARTON (80705-100-99) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 80705-100-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →